JP2022543070A5 - - Google Patents

Info

Publication number
JP2022543070A5
JP2022543070A5 JP2022506525A JP2022506525A JP2022543070A5 JP 2022543070 A5 JP2022543070 A5 JP 2022543070A5 JP 2022506525 A JP2022506525 A JP 2022506525A JP 2022506525 A JP2022506525 A JP 2022506525A JP 2022543070 A5 JP2022543070 A5 JP 2022543070A5
Authority
JP
Japan
Prior art keywords
nanocage
fusion protein
fragment
ferritin
monomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022506525A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022543070A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/051061 external-priority patent/WO2021016724A1/en
Publication of JP2022543070A publication Critical patent/JP2022543070A/ja
Publication of JP2022543070A5 publication Critical patent/JP2022543070A5/ja
Priority to JP2025154827A priority Critical patent/JP2026004351A/ja
Pending legal-status Critical Current

Links

JP2022506525A 2019-08-01 2020-07-31 多価及び多重特異性ナノ粒子プラットフォーム及び方法 Pending JP2022543070A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025154827A JP2026004351A (ja) 2019-08-01 2025-09-18 多価及び多重特異性ナノ粒子プラットフォーム及び方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962881899P 2019-08-01 2019-08-01
US62/881,899 2019-08-01
PCT/CA2020/051061 WO2021016724A1 (en) 2019-08-01 2020-07-31 Multi-valent and multi-specific nanoparticle platforms and methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025154827A Division JP2026004351A (ja) 2019-08-01 2025-09-18 多価及び多重特異性ナノ粒子プラットフォーム及び方法

Publications (2)

Publication Number Publication Date
JP2022543070A JP2022543070A (ja) 2022-10-07
JP2022543070A5 true JP2022543070A5 (cg-RX-API-DMAC7.html) 2023-08-08

Family

ID=74228187

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022506525A Pending JP2022543070A (ja) 2019-08-01 2020-07-31 多価及び多重特異性ナノ粒子プラットフォーム及び方法
JP2025154827A Pending JP2026004351A (ja) 2019-08-01 2025-09-18 多価及び多重特異性ナノ粒子プラットフォーム及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025154827A Pending JP2026004351A (ja) 2019-08-01 2025-09-18 多価及び多重特異性ナノ粒子プラットフォーム及び方法

Country Status (10)

Country Link
US (1) US20230145060A1 (cg-RX-API-DMAC7.html)
EP (1) EP4007779A4 (cg-RX-API-DMAC7.html)
JP (2) JP2022543070A (cg-RX-API-DMAC7.html)
KR (1) KR20220107151A (cg-RX-API-DMAC7.html)
CN (3) CN121203033A (cg-RX-API-DMAC7.html)
AU (1) AU2020320459A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022001800A2 (cg-RX-API-DMAC7.html)
CA (1) CA3149320A1 (cg-RX-API-DMAC7.html)
MX (1) MX2022001387A (cg-RX-API-DMAC7.html)
WO (1) WO2021016724A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220411508A1 (en) * 2019-09-09 2022-12-29 The Regents Of The University Of California Compositions and methods for making and using multispecific antibodies
CN117157328A (zh) * 2021-01-28 2023-12-01 儿童医院 Multabody构建体、组合物和方法
EP4370558A4 (en) * 2021-07-12 2025-09-10 Hospital For Sick Children OPTIMIZED MULTIBODY CONSTRUCTS, COMPOSITIONS AND METHODS
MX2024003140A (es) * 2021-09-13 2024-06-24 Hospital For Sick Children Construcciones, composiciones y metodos de multabody optimizados.
MX2024003139A (es) * 2021-09-13 2024-06-24 Hospital For Sick Children Multabody dirigido a dr5 para el tratamiento del cancer.
EP4416189A4 (en) * 2021-10-16 2025-08-27 Hospital For Sick Children MODIFIED MULTIBODY CONSTRUCTS, COMPOSITIONS AND METHODS TARGETING SARS-CoV-2
US20250002564A1 (en) * 2021-10-16 2025-01-02 The Hospital For Sick Children Modified multabody constructs, compositions, and methods
CN116804062A (zh) * 2022-03-23 2023-09-26 昆山新蕴达生物科技有限公司 一种FcRn结合纳米颗粒及其用途
CN119968382A (zh) * 2022-09-27 2025-05-09 科力博株式会社 包含主氨基酸由带电和极性氨基酸组成的肽标签并形成自组装体的融合蛋白及使用其纯化重组蛋白的方法
WO2024071970A1 (ko) * 2022-09-27 2024-04-04 크리포 주식회사 주요 아미노산이 전하성 아미노산으로 구성된 펩타이드 태그를 포함하여 자가 조립체를 형성하는 융합 단백질 및 이를 이용하여 재조합 단백질을 정제하는 방법
KR102946895B1 (ko) * 2022-10-21 2026-04-02 충남대학교산학협력단 SARS-CoV-2 S1 유래 단백질 및 항체 Fc 영역 단백질을 표면에 동시에 디스플레이하는 페리틴 단백질 구조체 및 이의 코로나바이러스 SARS-CoV-2에 대한 백신 용도
WO2024099273A1 (zh) * 2022-11-07 2024-05-16 厦门大学 一种融合蛋白以及包含其的颗粒化的抗原
EP4634238A1 (en) * 2022-12-18 2025-10-22 Radiant Biotherapeutics Inc. Multivalent hematopoietic cell engagers or activators
AU2023407259A1 (en) * 2022-12-18 2025-06-26 Radiant Biotherapeutics Inc. Multivalent and multispecific cytokine antagonists
CN115819626B (zh) * 2022-12-23 2026-04-28 北京吉诺卫生物科技有限公司 重组铁蛋白纳米颗粒及其制备方法
CN121127490A (zh) * 2022-12-28 2025-12-12 生物技术欧洲股份公司 靶向hiv的rna组合物
WO2024254514A1 (en) * 2023-06-08 2024-12-12 The University Of North Carolina At Chapel Hill Engineered antibody fusion proteins with modulable binding constants and their applications
CN116715780A (zh) * 2023-06-09 2023-09-08 中国人民解放军陆军军医大学 重组铜绿假单胞菌纳米颗粒蛋白及其制备方法和应用
WO2025054730A1 (en) * 2023-09-13 2025-03-20 The Hospital For Sick Children Hiv-1-targeted multabody constructs, compositions, and methods
WO2026003586A2 (en) * 2024-06-27 2026-01-02 Popvax Private Limited Multisubunit herpesvirus vaccines and therapeutics
WO2026092903A1 (en) 2024-10-29 2026-05-07 Albert-Ludwigs-Universität Freiburg Körperschaft Des Öffentlichen Rechts Encapsulation of dimer or tandem-enzymes within capsid proteins, in particular within engineered encapsulins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7097841B2 (en) * 2002-05-10 2006-08-29 New Century Pharmaceuticals, Inc. Ferritin fusion proteins for use in vaccines and other applications
KR20160094550A (ko) * 2015-01-30 2016-08-10 동국대학교 산학협력단 단일사슬항체조각과 페리틴을 포함하는 융합단백질 및 그의 용도
CA3071922A1 (en) * 2017-08-04 2019-02-07 The Governing Council Of The University Of Toronto Nanoparticle platform for antibody and vaccine delivery

Similar Documents

Publication Publication Date Title
US20030198956A1 (en) Staged assembly of nanostructures
US20040018587A1 (en) Nanostructures containing antibody assembly units
CN114867754A (zh) 多价和多特异性纳米颗粒平台和方法
JP2023504914A5 (cg-RX-API-DMAC7.html)
CN112409480B (zh) 结合血清白蛋白的蛋白及其用途
US20230190910A1 (en) Scaffolded hiv-1 vaccine immunogens
JP2024504777A (ja) Multabody構築物、組成物および方法
JP2023553697A5 (cg-RX-API-DMAC7.html)
US20250263469A1 (en) Polypeptides targeting sars-cov-2 and related compositions and methods
JP2026004299A5 (cg-RX-API-DMAC7.html)
JP2023544211A5 (cg-RX-API-DMAC7.html)
US20250197481A1 (en) Antigen Binding Polypeptides, Antigen Binding Polypeptide Complexes and Methods of Use Thereof in HIV
EP3207064A1 (en) Methods and compostions involving protein g variants
RU2562165C2 (ru) Альфатела для ингибирования проникновения вич
CN116496389A (zh) 用于治疗hbv感染及相关疾病的表位肽及抗体
TW201118205A (en) Phage displaying system expressing single chain antibody
US20250011397A1 (en) Modified multabody constructs, compositions, and methods targeting sars-cov-2
US20250002564A1 (en) Modified multabody constructs, compositions, and methods
RU2022103853A (ru) Мультивалентные и мультиспецифические платформы наночастиц и способы
AU2003290260A1 (en) Peptide oligomers for use as HIV vaccines
CN116615255A (zh) 靶向SARS-CoV-2的多肽及相关组合物和方法
WO2025054730A1 (en) Hiv-1-targeted multabody constructs, compositions, and methods
Wu Molecular biorecognition of coiled-coil motifs in the construction of hybrid hydrogels and drug-free macromolecular therapeutics
Konrad Development of a covalent site-specific antibody labeling strategy by the use of photoactivable Z domains